交易 Bristol Myers BMY

BristolMyers實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

BristolMyers 新聞

張瑋庭 2026 Apr 24, 00:00

摩根士丹利下調2026年黃金目標價:深入剖析原因與未來展望

陳昊然 2026 Apr 24, 00:00

油市反常現象:地緣政治緊張下的價格穩定

盧昕穎 2026 Apr 24, 00:00

美國期中選舉:能源產業前景與投資影響分析

盧昕穎 2026 Apr 24, 00:00

Google TPU 進入新紀元:訓練與推理雙軌並行,搶攻 AI 算力版圖

林芷柔 2026 Apr 24, 00:00

英特爾股價飆升:財報前夕,市場預期是否已脫離現實?

黃達傑 2025 Oct 09, 16:00

臺灣值得關注的加密貨幣:比特幣(BTC)、以太坊(ETH)、索拉納(Solana,SOL)、零幣(Zcash,ZEC)

黃達傑 2025 Sep 29, 16:00

NIO 股票預測:NIO 今天下跌 5%,未來會怎樣?

黃達傑 2025 Sep 27, 16:00

比特幣價格預測:如何在台灣購買比特幣?

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

最新新聞

顯示更多
盧昕穎 2026 Apr 24, 00:00

特斯拉預告巨額資本支出增長,目標成為AI與機器人領域領導者

張瑋庭 2026 Apr 24, 00:00

聯準會人事懸而未決:鮑爾可能續任及其面臨的政治挑戰

張瑋庭 2026 Apr 24, 00:00

選區劃分策略失算:共和黨擔憂因重新劃分導致國會席位流失

張瑋庭 2026 Apr 24, 00:00

能源貿易巨頭備戰中東持久衝突,應對供應中斷並尋求獲利機會

陳昊然 2026 Apr 24, 00:00

美聯儲主席提名受阻:共和黨參議員阻撓,沃許前路艱難

許景桓 2026 Apr 24, 00:00

俄烏外交僵局:克里姆林宮設定普京澤連斯基峰會條件

張瑋庭 2026 Apr 24, 00:00

中東戰事推升通膨疑慮,經濟學家預測聯準會延後降息

許景桓 2026 Apr 24, 00:00

巴拿馬運河因伊朗衝突與亞洲強勁需求創航道通行費紀錄

聯絡方式

點差

0.37

點差(%)

0.6314 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期一

13:31 - 19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

119870283776

流通股份

2041735455

收益日期(下一個)

2001-08-07

現金殖利率 

2026-05-01

除息日

2026-04-02

遠期年股息率

2.52

遠期年現金殖利率

0.0429

每股盈餘

3.46

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, and to a lesser extent, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
林芷柔 2025 Oct 29, 16:00

進階交易策略:多頭部位 vs. 空頭部位,哪個更好?

黃達傑 2025 Oct 13, 16:00

Palantir(PLTR)股價預測:PLTR暴跌5%,Palantir股價會再度飆升嗎?

黃達傑 2025 Oct 13, 16:00

Nvidia(NVDA)股價今日走高:2026年目標價是多少?

Trustpilot